PROLONGED INTAKE OF CHLORAMBUCIL FOR OVARIAN-CANCER

Authors
KHALIL AM KHATIB RA SHAMSEDDINE AI SHARARA NH SEOUD MAF
Citation
Am. Khalil et al., PROLONGED INTAKE OF CHLORAMBUCIL FOR OVARIAN-CANCER, European journal of obstetrics, gynecology, and reproductive biology, 60(1), 1995, pp. 85-86
Citations number
5
Categorie Soggetti
Reproductive Biology","Obsetric & Gynecology
Journal title
European journal of obstetrics, gynecology, and reproductive biology → ACNP
ISSN journal
03012115
Volume
60
Issue
1
Year of publication
1995
Pages
85 - 86
Database
ISI
SICI code
0301-2115(1995)60:1<85:PIOCFO>2.0.ZU;2-Q
Abstract
The use of alkylating agents has been reported to be a cause of second ary leukemia particularly in patients surviving for 2 years or more af ter treatment of ovarian carcinoma. The risk of developing leukemia is possibly related to the duration of treatment and the total dose of a lkylating agents administered. We report a patient with epithelial ova rian carcinoma who received chlorambucil for 130 consecutive months wi th no clinical or laboratory evidence of leukemia.